Wilson Wolf Manufacturing Corporation Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Wilson Wolf Manufacturing Corporation's estimated annual revenue is currently $3.6M per year.(i)
  • Wilson Wolf Manufacturing Corporation's estimated revenue per employee is $155,000

Employee Data

  • Wilson Wolf Manufacturing Corporation has 23 Employees.(i)
  • Wilson Wolf Manufacturing Corporation grew their employee count by 5% last year.

Wilson Wolf Manufacturing Corporation's People

NameTitleEmail/Phone
1
Founder and CEO focused on solving cell and gene therapy manufacturing challengesReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Director OperationsReveal Email/Phone
4
Director QA/RAReveal Email/Phone
5
Quality ManagerReveal Email/Phone
6
Warehouse, Safety, and Inventory ManagerReveal Email/Phone
7
Senior R&D EngineerReveal Email/Phone
8
Admin. in EOS/Finance/Facilities/HR/ITReveal Email/Phone
9
Special Projects LiaisonReveal Email/Phone
10
Human Resources / FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M509%N/AN/A
#2
$7.4M48-35%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.3M2-91%N/AN/A
#5
$3.6M235%N/AN/A
#6
$0.9M6-33%N/AN/A
#7
$5M323%N/AN/A
#8
$14.7M959%N/AN/A
#9
$14.7M950%$20.5MN/A
#10
$27.9M14413%$39.1MN/A
Add Company

What Is Wilson Wolf Manufacturing Corporation?

Wilson Wolf Manufacturing Corporation designs, manufactures, & markets cell culture devices including gas permeable cell culture systems. Our main focus is on expanding the G-Rex® production platform to meet the needs of the T cell therapy field. By eliminating the need for active gas exchange, rocking or stirring, these robust devices yield a more consistent and cost effective cell product than conventional culture systems. The G-Rex technology consistently yields larger, maximum density cell populations that are achieved through shortened culture durations, with no technician interventions or media exchange required, and with reduced overall media usage. Devices range from research & development through large scale, closed systems designed to meet the needs of commercial applications. Contact us with any questions and to find out how our expertise in the adoptive cell therapy field can be utilized to help your organization develop commercially viable manufacturing processes.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A23-49%N/A
#2
$3M244%N/A
#3
N/A24-8%N/A
#4
$5.5M24-17%N/A
#5
$5.4M24-8%N/A